{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T13:53:09Z","timestamp":1790776389498,"version":"4.1.0"},"reference-count":28,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,3,26]],"date-time":"2019-03-26T00:00:00Z","timestamp":1553558400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007013","name":"F. Hoffmann-La Roche","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007013","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","gynecologiconcology-online.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1016\/j.ygyno.2019.03.250","type":"journal-article","created":{"date-parts":[[2019,4,4]],"date-time":"2019-04-04T06:45:38Z","timestamp":1554360338000},"page":"521-529","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":68,"title":["The efficacy and safety of Tipapkinogen Sovacivec therapeutic HPV vaccine in cervical intraepithelial neoplasia grades 2 and 3: Randomized controlled phase II trial with 2.5\u202fyears of follow-up"],"prefix":"10.1016","volume":"153","author":[{"given":"Diane M.","family":"Harper","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pekka","family":"Nieminen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gilbert","family":"Donders","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark H.","family":"Einstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco","family":"Garcia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Warner K.","family":"Huh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark H.","family":"Stoler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katerina","family":"Glavini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gemma","family":"Attley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Marc","family":"Limacher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Berangere","family":"Bastien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Calleja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ygyno.2019.03.250_bb0005","doi-asserted-by":"crossref","unstructured":"Alvarez RD, Huh WK, Bae S, Lamb LS Jr, Conner MG, Boyer J, et al. A pilot study of pNGVL4a-CRT\/E7(detox) for the treatment of patients with HPV16+ cervical intraepithelial neoplasia 2\/3 (CIN2\/3). Gynecol. Oncol.. 2016 Feb;140(2):245\u201352. doi:https:\/\/doi.org\/10.1016\/j.ygyno.2015.11.026.","DOI":"10.1016\/j.ygyno.2015.11.026"},{"issue":"12","key":"10.1016\/j.ygyno.2019.03.250_bb0010","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1016\/S1470-2045(17)30700-3","article-title":"Incomplete excision of cervical precancer as a predictor of treatment failure: a systematic review and meta-analysis","volume":"18","author":"Arbyn","year":"2017","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.ygyno.2019.03.250_bb0015","article-title":"Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","author":"Bray","year":"2018","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.ygyno.2019.03.250_bb0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2010.09.020","article-title":"Regression of high-grade cervical intraepithelial neoplasia with TG4001 targeted immunotherapy","volume":"204","author":"Brun","year":"2011","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"7","key":"10.1016\/j.ygyno.2019.03.250_bb0025","doi-asserted-by":"crossref","first-page":"e453","DOI":"10.1016\/S2214-109X(16)30099-7","article-title":"Global estimates of human papillomavirus vaccination coverage by region and income level: a pooled analysis","volume":"4","author":"Bruni","year":"2016","journal-title":"Lancet Glob. Health"},{"key":"10.1016\/j.ygyno.2019.03.250_bb0030","series-title":"ICO\/IARC Information Centre on HPV and Cancer (HPV Information Centre). Human Papillomavirus and Related Diseases in Americas. Summary Report 10 December 2018","author":"Bruni","year":"2018"},{"key":"10.1016\/j.ygyno.2019.03.250_bb0035","doi-asserted-by":"crossref","unstructured":"Byrom J, Douce G, Jones PW, Tucker H, Millinship J, Dhar K, et al. Should punch biopsies be used when high-grade disease is suspected at initial colposcopic assessment? A prospective study. Int. J. Gynecol. Cancer. 2006 Jan-Feb;16(1):253\u20136. doi:https:\/\/doi.org\/10.1111\/j.1525-1438.2006.00344.x","DOI":"10.1111\/j.1525-1438.2006.00344.x"},{"issue":"1","key":"10.1016\/j.ygyno.2019.03.250_bb0040","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1097\/LGT.0000000000000276","article-title":"Predictors of persistent or recurrent disease after loop electrosurgical excision procedure","volume":"21","author":"Cejtin","year":"2017","journal-title":"J. Low. Genit. Tract Dis."},{"issue":"1","key":"10.1016\/j.ygyno.2019.03.250_bb0045","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1007\/s12672-012-0125-7","article-title":"Requirement for stromal estrogen receptor alpha in cervical neoplasia","volume":"4","author":"Chung","year":"2013","journal-title":"Horm Cancer"},{"key":"10.1016\/j.ygyno.2019.03.250_bb0050","author":"Condoms and STDs"},{"key":"10.1016\/j.ygyno.2019.03.250_bb0055","doi-asserted-by":"crossref","unstructured":"Dai P, Wang W, Cao H, Avogadri F, Dai L, Drexler I, et al. Modified vaccinia virus Ankara triggers type I IFN production in murine conventional dendritic cells via a cGAS\/STING-mediated cytosolic DNA-sensing pathway. PLoS Pathog.. 2014 Apr 17;10(4): e1003989. doi:https:\/\/doi.org\/10.1371\/journal.ppat.1003989","DOI":"10.1371\/journal.ppat.1003989"},{"issue":"3","key":"10.1016\/j.ygyno.2019.03.250_bb0060","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.ygyno.2007.04.038","article-title":"Heat shock fusion protein-based immunotherapy for treatment of cervical intraepithelial neoplasia III","volume":"106","author":"Einstein","year":"2007","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2019.03.250_bb0065","doi-asserted-by":"crossref","unstructured":"Gage JC, Hanson VW, Abbey K, Dippery S, Gardner S, Kubota J, et al. Number of cervical biopsies and sensitivity of colposcopy. Obstet. Gynecol.. 2006 Aug;108(2):264\u201372. doi:https:\/\/doi.org\/10.1097\/01.AOG.0000220505.18525.85","DOI":"10.1097\/01.AOG.0000220505.18525.85"},{"issue":"2","key":"10.1016\/j.ygyno.2019.03.250_bb0070","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1002\/ijgo.12030","article-title":"Negative HPV testing among patients with biopsy-proven cervical intraepithelial neoplasia grade 2\/3 or cervical cancer","volume":"136","author":"Gonz\u00e1lez-Bosquet","year":"2017","journal-title":"Int. J. Gynaecol. Obstet."},{"issue":"4(10)","key":"10.1016\/j.ygyno.2019.03.250_bb0075","doi-asserted-by":"crossref","first-page":"e1031439","DOI":"10.1080\/2162402X.2015.1031439","article-title":"A phase I dose-escalation clinical trial of a peptide-based human papillomavirus therapeutic vaccine with Candida skin test reagent as a novel vaccine adjuvant for treating women with biopsy-proven cervical intraepithelial neoplasia 2\/3","volume":"27","author":"Greenfield","year":"2015","journal-title":"Oncoimmunology"},{"issue":"Apr","key":"10.1016\/j.ygyno.2019.03.250_bb0080","article-title":"HPV vaccines \u2013 a review of the first decade","volume":"22","author":"Harper","year":"2017","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2019.03.250_bb0085","doi-asserted-by":"crossref","first-page":"g6192","DOI":"10.1136\/bmj.g6192","article-title":"Fertility and early pregnancy outcomes after treatment for cervical intraepithelial neoplasia: systematic review and meta-analysis","volume":"349","author":"Kyrgiou","year":"2014","journal-title":"BMJ"},{"issue":"354","key":"10.1016\/j.ygyno.2019.03.250_bb0090","doi-asserted-by":"crossref","first-page":"i3633","DOI":"10.1136\/bmj.i3633","article-title":"Adverse obstetric outcomes after local treatment for cervical preinvasive and early invasive disease according to cone depth: systematic review and meta-analysis","volume":"28","author":"Kyrgiou","year":"2016","journal-title":"BMJ"},{"issue":"11","key":"10.1016\/j.ygyno.2019.03.250_bb0095","first-page":"CD012847","article-title":"Obstetric outcomes after conservative treatment for cervical intraepithelial lesions and early invasive disease","volume":"2","author":"Kyrgiou","year":"2017","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.ygyno.2019.03.250_bb0100","article-title":"Does LLETZ excision margin status predict residual disease in women who have undergone post-treatment cervical cytology and high-risk human papillomavirus testing?","author":"Palmer","year":"2015","journal-title":"Cytopathology"},{"issue":"3","key":"10.1016\/j.ygyno.2019.03.250_bb0105","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.ygyno.2007.05.038","article-title":"Weber JS. A phase II study of Hsp-7 (SGN-00101) in women with high-grade cervical intraepithelial neoplasia","volume":"106","author":"Roman","year":"2007","journal-title":"Gynecol. Oncol."},{"issue":"3","key":"10.1016\/j.ygyno.2019.03.250_bb0110","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.ijgo.2015.07.026","article-title":"Systematic reviews and meta-analyses of benefits and harms of cryotherapy, LEEP, and cold knife conization to treat cervical intraepithelial neoplasia","volume":"132","author":"Santesso","year":"2016","journal-title":"Int. J. Gynaecol. Obstet."},{"key":"10.1016\/j.ygyno.2019.03.250_bb0115","unstructured":"SAS Institute, Cary NC, USA version 9.4 (no doi)"},{"issue":"5","key":"10.1016\/j.ygyno.2019.03.250_bb0120","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/S1470-2045(08)70110-4","article-title":"Heterogeneity in CIN3 diagnosis","volume":"9","author":"Schiffman","year":"2008","journal-title":"Lancet Oncol."},{"issue":"4","key":"10.1016\/j.ygyno.2019.03.250_bb0125","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1097\/00128360-200210000-00002","article-title":"Clinical trials in cervical intraepithelial neoplasia: balancing the need for efficacy data with patient safety","volume":"6","author":"Silverman","year":"2002","journal-title":"J. Low. Genit. Tract Dis."},{"issue":"4","key":"10.1016\/j.ygyno.2019.03.250_bb0130","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1002\/jmv.23806","article-title":"Human papillomavirus type-specific persistence and recurrence after treatment for cervical dysplasia","volume":"86","author":"S\u00f6derlund-Strand","year":"2014","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.ygyno.2019.03.250_bb0135","author":"The case for starting sex education in kindergarten"},{"key":"10.1016\/j.ygyno.2019.03.250_bb0140","doi-asserted-by":"crossref","unstructured":"Trimble CL, Morrow MP, Kraynyak KA, Shen X, Dallas M, Yan J et al. Safety, efficacy, and immunogenicity of VGX-3100, a therapeutic synthetic DNA vaccine targeting human papillomavirus 16 and 18 E6 and E7 proteins for cervical intraepithelial neoplasia 2\/3: a randomised, double-blind, placebo-controlled phase 2b trial. Lancet. 2015 Sep 16. pii: S0140-6736(15)00239-1. doi:https:\/\/doi.org\/10.1016\/S0140-6736(15)00239-1","DOI":"10.1016\/S0140-6736(15)00239-1"}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825819304846?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825819304846?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T03:42:10Z","timestamp":1758771730000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825819304846"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6]]},"references-count":28,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,6]]}},"alternative-id":["S0090825819304846"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2019.03.250","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2019,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The efficacy and safety of Tipapkinogen Sovacivec therapeutic HPV vaccine in cervical intraepithelial neoplasia grades 2 and 3: Randomized controlled phase II trial with 2.5\u202fyears of follow-up","name":"articletitle","label":"Article Title"},{"value":"Gynecologic Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ygyno.2019.03.250","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}